Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update

… chronic obstructive pulmonary disease (COPD) in adult patients. Ohtuvayre is the first inhaled product with a novel mechanism of action available …

Share on Facebook

Tweet

Follow us

Save